• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性帕金森病的神经退行性变机制

Mechanisms of neurodegeneration in idiopathic Parkinson's disease.

作者信息

Schulz Jörg B

机构信息

Department of Neurodegeneration & Restorative Research, Center for Neurological Medicine, University Medical Center Göttingen, Germany.

出版信息

Parkinsonism Relat Disord. 2007;13 Suppl 3:S306-8. doi: 10.1016/S1353-8020(08)70021-X.

DOI:10.1016/S1353-8020(08)70021-X
PMID:18267255
Abstract

The discovery of mutations in hereditary forms of Parkinson's disease has implicated aggregation of a-synuclein, dysfunction of protein turnover and mitochondrial dysfunction as important mediators in the pathogenesis of Parkinson's disease. Subsequent studies have shown that these factors also represent hallmarks of idiopathic Parkinson's disease. Cell death mechanisms include excitotoxicity, calcium overload, apoptosis and autophagia. Here, I will briefly review the molecular mechanisms of neurodegeneration in Parkinson's disease and point out potential treatment options.

摘要

帕金森病遗传形式中突变的发现表明,α-突触核蛋白的聚集、蛋白质周转功能障碍和线粒体功能障碍是帕金森病发病机制中的重要介质。随后的研究表明,这些因素也是特发性帕金森病的特征。细胞死亡机制包括兴奋性毒性、钙超载、凋亡和自噬。在此,我将简要回顾帕金森病神经退行性变的分子机制,并指出潜在的治疗选择。

相似文献

1
Mechanisms of neurodegeneration in idiopathic Parkinson's disease.特发性帕金森病的神经退行性变机制
Parkinsonism Relat Disord. 2007;13 Suppl 3:S306-8. doi: 10.1016/S1353-8020(08)70021-X.
2
A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.一条将α-突触核蛋白与载脂蛋白E及β淀粉样肽联系起来的神经退行性变分子通路。
Nat Neurosci. 2008 Mar;11(3):301-8. doi: 10.1038/nn2058. Epub 2008 Feb 24.
3
A tale on animal models of Parkinson's disease.帕金森病动物模型的故事。
Mov Disord. 2011 May;26(6):993-1002. doi: 10.1002/mds.23696.
4
Olfactory dysfunction in Parkinson's disease.帕金森病中的嗅觉功能障碍。
Clin Neurosci. 1998;5(2):94-101.
5
The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease.自噬-溶酶体途径在帕金森病相关神经退行性变中的作用。
Brain. 2008 Aug;131(Pt 8):1969-78. doi: 10.1093/brain/awm318. Epub 2008 Jan 10.
6
Mitochondria and the link between neuroinflammation and neurodegeneration.线粒体与神经炎症和神经退行性变之间的联系。
J Alzheimers Dis. 2010;20 Suppl 2:S369-79. doi: 10.3233/JAD-2010-100543.
7
Mitochondria and neurodegeneration.线粒体与神经退行性变
Biosci Rep. 2007 Jun;27(1-3):87-104. doi: 10.1007/s10540-007-9038-z.
8
Recent clinical failures in Parkinson's disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases.近期帕金森病凋亡抑制剂的临床应用失败凸显了神经退行性疾病药物研发模式转变的必要性。
Biochem Pharmacol. 2006 Nov 15;72(10):1197-206. doi: 10.1016/j.bcp.2006.06.031. Epub 2006 Aug 9.
9
The law of mass action applied to neurodegenerative disease: a hypothesis concerning the etiology and pathogenesis of complex diseases.质量作用定律应用于神经退行性疾病:关于复杂疾病病因和发病机制的一种假说。
Hum Mol Genet. 2004 Apr 1;13 Spec No 1:R123-6. doi: 10.1093/hmg/ddh093. Epub 2004 Feb 19.
10
Clinical potential of minocycline for neurodegenerative disorders.米诺环素在神经退行性疾病中的临床应用潜力。
Neurobiol Dis. 2004 Dec;17(3):359-66. doi: 10.1016/j.nbd.2004.07.012.

引用本文的文献

1
Neuroprotective effects of osmotin in Parkinson's disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways.ossmotin 通过 AdipoR1/MAPK/AMPK/mTOR 信号通路对帕金森病相关病理的神经保护作用。
J Biomed Sci. 2023 Aug 11;30(1):66. doi: 10.1186/s12929-023-00961-z.
2
Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration.兴奋毒性、钙离子和线粒体:突触神经退行性变的三联体。
Transl Neurodegener. 2022 Jan 25;11(1):3. doi: 10.1186/s40035-021-00278-7.
3
Evaluation of the Anti-apoptotic and Anti-cytotoxic Effect of Epicatechin Gallate and Edaravone on SH-SY5Y Neuroblastoma Cells.
表儿茶素没食子酸酯和依达拉奉对SH-SY5Y神经母细胞瘤细胞的抗凋亡和抗细胞毒性作用评估
Basic Clin Neurosci. 2019 Nov-Dec;10(6):619-630. doi: 10.32598/bcn.9.10.1159.2. Epub 2019 Nov 1.
4
Rhodopsin: A Potential Biomarker for Neurodegenerative Diseases.视紫红质:一种神经退行性疾病的潜在生物标志物。
Front Neurosci. 2020 Apr 15;14:326. doi: 10.3389/fnins.2020.00326. eCollection 2020.
5
Acidic Ca stores in neurodegeneration.神经退行性变中的酸性钙储存
Messenger (Los Angel). 2016 Jun 1;5(1-2):37-55. doi: 10.1166/msr.2016.1054.
6
Early involvement of lysosome dysfunction in the degeneration of cerebral cortical neurons caused by the lipid peroxidation product 4-hydroxynonenal.溶酶体功能障碍早期参与脂质过氧化产物4-羟基壬烯醛所致大脑皮质神经元变性。
J Neurochem. 2017 Mar;140(6):941-954. doi: 10.1111/jnc.13957. Epub 2017 Feb 16.
7
Bcl-2 homologue Debcl enhances α-synuclein-induced phenotypes in Drosophila.Bcl-2同源物Debcl增强果蝇中α-突触核蛋白诱导的表型。
PeerJ. 2016 Sep 15;4:e2461. doi: 10.7717/peerj.2461. eCollection 2016.
8
An autism-associated mutation in CaV1.3 channels has opposing effects on voltage- and Ca(2+)-dependent regulation.CaV1.3通道中一种与自闭症相关的突变对电压依赖性和钙依赖性调节具有相反的作用。
Sci Rep. 2016 Jun 3;6:27235. doi: 10.1038/srep27235.
9
The Bcl-2 homologue Buffy rescues α-synuclein-induced Parkinson disease-like phenotypes in Drosophila.Bcl-2同源物Buffy可挽救果蝇中α-突触核蛋白诱导的帕金森病样表型。
BMC Neurosci. 2016 May 18;17(1):24. doi: 10.1186/s12868-016-0261-z.
10
Reduced Risk of Parkinson's Disease in Users of Calcium Channel Blockers: A Meta-Analysis.钙通道阻滞剂使用者患帕金森病风险降低:一项荟萃分析
Int J Chronic Dis. 2015;2015:697404. doi: 10.1155/2015/697404. Epub 2015 Feb 3.